Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Serum Acetaminophen-Cysteine (APAP-cys) Adduct Concentrations After 16 Days of Acetaminophen Dosing

NCT01021410 is registered in ClinicalTrials.gov with Denver Health and Hospital Authority as lead sponsor.

NCT NCT01021410
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01021410 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Serum Acetaminophen-Cysteine (APAP-cys) Adduct Concentrations After 16 Days of Acetaminophen Dosing
Lead sponsor
Denver Health and Hospital Authority
Phase
Observational
Overall status
Completed
Start date
November 30, 2009
Completion date
March 31, 2011
Enrollment
100 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

acetaminophen-protein adduct formation